Developing a group treatment to help teens at risk for serious mental illness
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
This study is testing a new group program to help high school students with mild signs of depression or anxiety build resilience and prevent serious mental health issues.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 14 Years to 19 Years |
| Sex | All |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT05962879 on ClinicalTrials.gov |
What this trial studies
This research aims to create a brief group-based treatment called Resilience Training for Teens, designed to support high school students who exhibit mild symptoms of depression, anxiety, or unusual feelings. The intervention will be tested to evaluate its effectiveness in preventing the development of serious mental illnesses among adolescents. Participants will be enrolled from grades 9 to 12 and will engage in group sessions focused on building resilience and coping strategies.
Who should consider this trial
Good fit: Ideal candidates are high school students aged 14 to 19 who have experienced at least one psychotic experience and are willing to participate with parental consent.
Not a fit: Patients currently on psychotropic medications or receiving psychotherapeutic interventions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the risk of serious mental illness in adolescents.
How similar studies have performed: Other studies have shown promise in using resilience training and similar interventions for mental health, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Currently enrolled in 9th through 12th grade and between the ages of 14 and 19 * Endorsed at least one psychotic experience * Provided contact information * Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18) * Have a parent or legal guardian who is able and willing to participate in a parent session * Competent and willing to provide written informed assent (if under the age of 18) or consent (if age 18 or older) * Able to communicate in English Exclusion Criteria: * Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence * Currently obtaining psychotherapeutic intervention
Where this trial is running
Boston, Massachusetts
- Massachusetts General Hospital — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Study coordinator: Nicole R DeTore, PhD
- Email: ndetore@mgh.harvard.edu
- Phone: 617-726-2065
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.